Viewing Study NCT01262651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:30 PM
Study NCT ID: NCT01262651
Status: COMPLETED
Last Update Posted: 2018-04-23
First Post: 2010-12-16
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
Sponsor: GW Pharmaceuticals Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer pain View
None Opioid therapy View
None Inadequate analgesia View
None Optimized chronic opioid therapy View